PMC9379108_01
Front view before injecting filler.
CCID-15-1627-g0001.jpg
PMC9379108_01_CCID-15-1627-g0001.jpg
f0001
There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
Profile view before injecting filler.
CCID-15-1627-g0002.jpg
PMC9379108_01_CCID-15-1627-g0002.jpg
f0002
There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
Front view after injecting 1ml of filler.
CCID-15-1627-g0003.jpg
PMC9379108_01_CCID-15-1627-g0003.jpg
f0003
There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
Profile view after injecting 1ml of filler.
CCID-15-1627-g0004.jpg
PMC9379108_01_CCID-15-1627-g0004.jpg
f0004
There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
Front view after injecting 2nd ml of filler.
CCID-15-1627-g0005.jpg
PMC9379108_01_CCID-15-1627-g0005.jpg
f0005
There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).
Profile view after injecting 2nd ml of filler.
CCID-15-1627-g0006.jpg
PMC9379108_01_CCID-15-1627-g0006.jpg
f0006
There were no signs of reactivation of the disease at the 1 year of follow-up (Figures 1-6).